Novabay pharmaceuticals stock forecast
WebMar 29, 2024 · Analyst Forecast The average price target for NBY is $15.30, which is 844.44% higher than the current price. The consensus rating is "Buy". Stock Forecasts Stock Splits The last stock split was on November 16, 2024. It was a … WebMar 13, 2024 · Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for NBY stock is $ 15.3 , which predicts an increase of 926.85%. The …
Novabay pharmaceuticals stock forecast
Did you know?
WebThis Year's Lineup Has Left Us Speechless. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ... WebMar 30, 2024 · NovaBay Pharmaceuticals, Inc. (NBY) Price Targets Enter Symbol Price Target Based on short-term price targets offered by two analysts, the average price target …
WebNovaBay Pharmaceuticals, Inc. (NBY) owns Avenova, which is EPA listed as an effective disinfectant for monkeypox. On 5/20/2024 Ascendiant Capital Markets brokerage set a price target of $4.00 for NovaBay Pharmaceuticals, Inc. (NBY). The stock is now only 0.20usd. WebMar 29, 2024 · NovaBay PharmaceuticalsNBY is set to give its latest quarterly earnings report on Thursday, 2024-03-30. Here's what investors need to know before the announcement. Analysts estimate that NovaBay Pharmaceuticals will report an earnings per share(EPS) of $-0.17.
WebMar 10, 2024 · Stock Detail NovaBay Pharmaceuticals, Inc. Stock Chart. COMPANY. NovaBay Pharmaceuticals, Inc. NYSE AMEX: NBY. Russell Microcap Index component. IR … WebNovabay Pharmaceuticals Simple Moving Average . Analysis of Novabay Pharmaceuticals Simple Moving Average, A two period moving average forecast for Novabay Pharmaceuticals is based on an daily price series in which the stock pr...
WebStock Price Forecast The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of... NovaBay Pharmaceuticals Inc (NYSE American:NBY) 1.50. Delayed Data. As of … Annual Data Quarterly Data; All Currency in US Dollars 4 Year Trend; 2015 2016 2024 … NBY NovaBay Pharmaceuticals Inc: $3.1M: NM-8.11% ... Most stock quote data … NovaBay Pharmaceuticals Inc (NYSE American:NBY) Real-Time Quotes. 1.70. … NovaBay Pharmaceuticals Inc (NYSE American:NBY) 1.43. Delayed Data. As of …
WebNovaBay Pharmaceuticals, Inc About Technology Brands Investors News Contact TOP About Management Team Board of Directors Contact Us Technology Pure HOCI Brands … mary katherine horony cummingsWebMar 29, 2024 · Shares of NovaBay Pharmaceuticals were trading at $1.61 as of March 28. Over the last 52-week period, shares are down 84.31%. Given that these returns are generally negative, long-term... hurry faceWebNovaBay Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 47 means that 53% of … hurryflow ltdWebNovaBay Pharmaceuticals reported Asset Turnover of 0.61 in 2024. Book Value per Share is likely to rise to 7.53 in 2024, whereas Current Ratio is likely to drop 3.11 in 2024. This module is based on analyzing investor sentiment around taking a position in NovaBay Pharmaceuticals. mary katherine king realtorWebNovaBay Pharmaceuticals' stock pulls back 15%, after rocketing 875% on Monday Jun. 11, 2024 at 10:37 a.m. ET by Tomi Kilgore NovaBay's stock halted for volatility 18 times as it … mary katherine joyce rise of the guardiansWebNovaBay Pharmaceuticals (NYSEAM:NBY) earnings and revenue forecasts, price targets, future return on equity. Compare NovaBay Pharmaceuticals, Inc.'s growth forecast … mary katherine johnson obgynWebMar 14, 2024 · NovaBay Pharmaceuticals, Inc. develops and sells problem-solving, accessible solutions for improved well-being. Our leading product, Avenova® … mary katherine knipp cedaredge co